7-8 250cx Series Maternal/Fetal Monitor Revision C
2036946-001
Maternal Heart/Pulse Rate Monitoring: Maternal ECG Monitoring
CAUTION•
FDA POSTMARKET SAFETY ALERT—the United States FDA
Center for Devices and Radiological Health issued a safety
bulletin October 14, 1998. This bulletin states “that minute
ventilation rate-adaptive implantable pacemakers can occasionally
interact with certain cardiac monitoring and diagnostic equipment,
causing the pacemakers to pace at their maximum programmed
rate.” The FDA further recommends precautions to take into
consideration for patients with these types of pacemakers. These
precautions include disabling the rate responsive mode and
enabling an alternate pace mode. For more information contact:
Office of Surveillance and Biometrics, CDRH, FDA
1350 Piccard Drive, Mail Stop HFZ-510
Rockville, MD 20850
USA
MECG Waveform
When MECG monitoring is employed, the MECG waveform can be displayed and
printed—independent of the MHR/P source. Refer to Chapter 14, “Waveforms”.
To Next Page
Loading...
Need help?
General
